Norepinephrine kinetics and dynamics in septic shock and trauma patients - PubMed (original) (raw)
doi: 10.1093/bja/aei259. Epub 2005 Oct 14.
Affiliations
- PMID: 16227334
- DOI: 10.1093/bja/aei259
Free article
Norepinephrine kinetics and dynamics in septic shock and trauma patients
H Beloeil et al. Br J Anaesth. 2005 Dec.
Free article
Abstract
Background: There is considerable variability in the inter-patient response to norepinephrine. Pharmacokinetic studies of dopamine infusion in volunteers and in patients have also shown large variability. The purpose of this study was to define the pharmacokinetics of norepinephrine in septic shock and trauma patients.
Methods: After Ethical Committee approval and written informed family consent, 12 patients with septic shock and 11 trauma patients requiring norepinephrine infusion were studied. Norepinephrine dose was increased in three successive steps of 0.1 mg kg(-1) min(-1) at 15-min intervals (20% maximum allowed increase in arterial pressure). Arterial blood was sampled before and at 0.5, 13, and 15 min after each infusion rate change and 30 s, 1, 2, 5, 10, and 15 min after return to baseline dosing. Norepinephrine was assayed by HPLC. The pharmacokinetics were modelled using NONMEM (one-compartment model). The effects of group, body weight (BW), gender and SAPS II (Simplified Acute Physiology Score II) [Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993; 270: 2957-63] patients score on clearance (CL) and volume of distribution (V) were tested.
Results: Group, gender, and BW did not influence CL or V. CL was negatively related to SAPS II. CL and T(1/2) varied from 3 litre min(-1) and 2 min, respectively, when SAPS II=20 to 0.9 litre min(-1) and 6.8 min when SAPS II=60.
Conclusion: In trauma patients and in septic shock patients, norepinephrine clearance is negatively related to SAPS II.
Similar articles
- Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.
Radosevich JJ, Patanwala AE, Erstad BL. Radosevich JJ, et al. Am J Crit Care. 2016 Jan;25(1):27-32. doi: 10.4037/ajcc2016667. Am J Crit Care. 2016. PMID: 26724290 - Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status.
Abboud I, Lerolle N, Urien S, Tadié JM, Leviel F, Fagon JY, Faisy C. Abboud I, et al. Crit Care. 2009;13(4):R120. doi: 10.1186/cc7972. Epub 2009 Jul 21. Crit Care. 2009. PMID: 19622169 Free PMC article. - Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A, Ertmer C, Lange M, Dünser M, Rehberg S, Van Aken H, Pietropaoli P, Westphal M. Morelli A, et al. Br J Anaesth. 2008 Apr;100(4):494-503. doi: 10.1093/bja/aen017. Epub 2008 Feb 27. Br J Anaesth. 2008. PMID: 18308741 Clinical Trial. - Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riché F, Laisné MJ, Payen D, Mebazaa A. Benchekroune S, et al. J Trauma. 2008 May;64(5):1188-95. doi: 10.1097/TA.0b013e31811f3a45. J Trauma. 2008. PMID: 18469640 Clinical Trial. - A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
Bissell BD, Browder K, McKenzie M, Flannery AH. Bissell BD, et al. Ann Pharmacother. 2018 Sep;52(9):920-927. doi: 10.1177/1060028018767899. Epub 2018 Mar 27. Ann Pharmacother. 2018. PMID: 29582666 Review.
Cited by
- Catecholamine dosing and survival in adult intensive care unit patients.
Kastrup M, Braun J, Kaffarnik M, von Dossow-Hanfstingl V, Ahlborn R, Wernecke KD, Spies C. Kastrup M, et al. World J Surg. 2013 Apr;37(4):766-73. doi: 10.1007/s00268-013-1926-8. World J Surg. 2013. PMID: 23370459 - Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series.
Nakamura K, Nakano H, Naraba H, Mochizuki M, Takahashi Y, Sonoo T, Hashimoto H, Abe T, Hayakawa M, Yamakawa K. Nakamura K, et al. Front Med (Lausanne). 2021 May 4;8:644195. doi: 10.3389/fmed.2021.644195. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34017842 Free PMC article. - Effect of noradrenaline on propofol-induced mitochondrial dysfunction in human skeletal muscle cells.
Krajčová A, Skagen C, Džupa V, Urban T, Rustan AC, Jiroutková K, Bakalář B, Thoresen GH, Duška F. Krajčová A, et al. Intensive Care Med Exp. 2022 Nov 8;10(1):47. doi: 10.1186/s40635-022-00474-3. Intensive Care Med Exp. 2022. PMID: 36346511 Free PMC article. - Evaluation of Dose Requirements Using Weight-Based versus Non-Weight-Based Dosing of Norepinephrine to Achieve a Goal Mean Arterial Pressure in Patients with Septic Shock.
Selby AR, Khan NS, Dadashian T, Hall Nd RG. Selby AR, et al. J Clin Med. 2023 Feb 8;12(4):1344. doi: 10.3390/jcm12041344. J Clin Med. 2023. PMID: 36835880 Free PMC article. - Population Pharmacokinetic Modelling of Norepinephrine in Healthy Volunteers Prior to and During General Anesthesia.
Li Y, Koomen JV, Eleveld DJ, van den Berg JP, Vos JJ, de Keijzer IN, Struys MMRF, Colin PJ. Li Y, et al. Clin Pharmacokinet. 2024 Nov;63(11):1597-1608. doi: 10.1007/s40262-024-01430-y. Epub 2024 Oct 27. Clin Pharmacokinet. 2024. PMID: 39465453 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous